Which has the lower trailing P/E, AMPH or CRON?

AMPH has the lower trailing P/E: AMPH trades at 15.33 and CRON at 18.14. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AMPH or CRON?

Over the past five years, CRON grew revenue faster — AMPH at a 13.71% CAGR versus CRON at 31.80%.

Is AMPH or CRON more profitable?

CRON runs the higher net margin — AMPH at 10.76% versus CRON at 30.98%.

How have AMPH and CRON total returns compared?

Over the past 10 years, AMPH delivered 2.47% and CRON delivered 13.62% annualized total return. Past performance doesn't predict future results.

Amphastar Pharmaceuticals, Inc. (AMPH) vs Cronos Group Inc. (CRON)

A side-by-side comparison of Amphastar Pharmaceuticals, Inc. and Cronos Group Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AMPH

Amphastar Pharmaceuticals, Inc.

$1.14B

$25.91HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

CRON

Cronos Group Inc.

$1.23B

$3.29HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — AMPH vs CRON

growth of $100 · dividends reinvested · last 10y

AMPH +33.7% (+2.9%/yr)CRON +258.4% (+13.6%/yr)CRON compounded faster over this window

AMPH CRON

AMPH vs CRON: by the numbers

•CRON is the larger company ($1.23B vs $1.14B market cap).
•AMPH trades at the lower trailing earnings multiple (15.33 vs 18.14 P/E), one valuation lens rather than an overall verdict.
•CRON converts more revenue to profit (30.98% vs 10.76% net margin).
•CRON grew revenue faster over the past five years (31.80% vs 13.71% CAGR).

Metrics side by side

Valuation

Metric	AMPH	CRON
P/E ratio	15.33	18.14
Forward P/E	8.72	N/A
PEG ratio	0.11	N/A
P/S ratio	1.56	5.45
P/B ratio	1.49	1.15
EV / EBITDA	8.95	28.08
FCF yield	13.38%	4.05%

Profitability

Metric	AMPH	CRON
Gross margin	47.68%	36.16%
Operating margin	15.66%	-11.96%
Net margin	10.76%	30.98%
ROE	10.23%	6.53%
ROIC	5.93%	1.12%

Growth (annualized)

Metric	AMPH	CRON
Revenue CAGR (5Y)	13.71%	31.80%
EPS CAGR (5Y)	134.23%	N/A
FCF CAGR (5Y)	23.90%	N/A
Total return CAGR (5Y)	6.13%	-9.92%

Frequently asked

Which has the lower trailing P/E, AMPH or CRON?: AMPH has the lower trailing P/E: AMPH trades at 15.33 and CRON at 18.14. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AMPH or CRON?: Over the past five years, CRON grew revenue faster — AMPH at a 13.71% CAGR versus CRON at 31.80%.
Is AMPH or CRON more profitable?: CRON runs the higher net margin — AMPH at 10.76% versus CRON at 30.98%.
How have AMPH and CRON total returns compared?: Over the past 10 years, AMPH delivered 2.47% and CRON delivered 13.62% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AMPH analysis Full CRON analysis Interactive comparison tool

Dig into the metrics

Amphastar Pharmaceuticals P/E ratio Cronos P/E ratio Amphastar Pharmaceuticals ROE Cronos ROE Amphastar Pharmaceuticals operating margin Cronos operating margin Amphastar Pharmaceuticals revenue growth Cronos revenue growth Amphastar Pharmaceuticals free cash flow Cronos free cash flow

Amphastar Pharmaceuticals & Cronos appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.